[en] Gliomas are the most common CNS tumours in children and present either as circumscribed tumours or diffusely infiltrative neoplasms. Diffuse gliomas develop both in the cerebral hemispheres and the brainstem and have a poor prognosis. Guidelines for the therapy of these tumours are still debated. In this study, we reviewed the clinical features of 27 consecutive patients with diffuse gliomas admitted to the Department of Paediatrics of CHR Citadelle, University of Liege, between 1985 and 2005. We review their clinical presentation, diagnosis, treatment and outcome with reference to the published literature.
Disciplines :
Neurology Pediatrics Oncology
Author, co-author :
Piette, Caroline ; Université de Liège - ULiège > Département des sciences cliniques > Pédiatrie
Deprez, Manuel ; Université de Liège - ULiège > Département des sciences cliniques > Neuropathologie
Born, Jacques
Michotte, Alex
Munaut, Carine ; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
BRADA M., VIVIERS L., ABSON C., HINES F., BRITTON J. et al. Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann. Oncol., 2003, 14: 1715-1721.
BRONISCER A., GAJJAR A. Supratentorial high-grade astrocytoma and diffuse brainstem glioma: Two challenges for the pediatric oncologist. Oncologist., 2004, 9: 197-206.
CAMPBELL J. W., POLLACK I. F., MARTINEZ A. J., SHULTZ B. High-grade astrocytomas in children: Radiologically complete resection is associated with an excellent long-term prognosis. Neurosurgery, 1996, 38: 258-264.
DUFOUR C., GRILL J., LELLOUCH-TUBIANA A., PUGET S., CHASTAGNER P. et al. High-grade glioma in children under 5 years of age: A chemotherapy only approach with the BBSFOP protocol. Eur. J. Cancer, 2006, 42: 2939-2945.
FINLAY J. L., BOYETT J. M., YATES A. J., WISOFF J. H., MILSTEIN J. M. et al. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. J. Clin. Oncol., 1995, 13: 112-123.
FISHER B. J., LEIGHTON C. C., VUJOVIC O., MACDONALD D. R., STITT L. Results of a policy of surveillance alone after surgical management of pediatric low grade gliomas. Int. J. Radiat. Oncol. Biol. Phys., 2001, 51: 704-710.
FLEURY A., MENEGOZ F., GROSCLAUDE P., DAURES J. P., HENRY-AMAR M. et al. Descriptive epidemiology of cerebral gliomas in France. Cancer, 1997, 79: 1195-1202.
FREEMAN C. R., KEPNER J., KUN L. E., SANFORD R. A., KADOTA R. et al. A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas? Int. J. Radiat. Oncol. Biol. Phys., 2000, 47: 561-564.
GREENBERG R. S., SHUSTER J. L., Jr. Epidemiology of cancer in children. Epidemiol. Rev., 1985, 7: 22-48.
GUTHRIE B. L., LAWS E. R. Jr. Supratentorial low-grade gliomas. Neurosurg. Clin. N. Am., 1990, 1: 37-48.
HARGRAVE D., BARTELS U., BOUFFET E. Diffuse brainstem glioma in children: Critical review of clinical trials. Lancet Oncol., 2006, 7: 241-248.
HUNTER S., YOUNG A., OLSON J., BRAT D. J., BOWERS G. et al. Differential expression between pilocytic and anaplastic astrocytomas: identification of apolipoprotein D as a marker for low-grade, non-infiltrating primary CNS neoplasms. J. Neuropathol. Exp. Neurol., 2002, 61: 275-281.
KRAMM C. M., WAGNER S., VAN GOOL S., SCHMID H., STRATER R. et al. Improved survival after gross total resection of malignant gliomas in pediatric patients from the HIT-GBM studies. Anticancer Res., 2006, 26: 3773-3779.
OHGAKI H., KLEIHUES P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J. Neuropathol. Exp. Neurol., 2005, 64: 479-489.
PACKER R. J., NICHOLSON H. S., VEZINA L. G., JOHNSON D. L. Brainstem gliomas. Neurosurg. Clin. N. Am., 1992, 3: 863-879.
PACKER R. J., PRADOS M., PHILLIPS P., NICHOLSON H. S., BOYETT J. M. et al. Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant beta-interferon and hyper-fractionated radiation therapy: A childrens cancer group phase I/II study. Cancer, 1996, 77: 2150-2156.
PERIS-BONET R., MARTINEZ-GARCIA C., LACOUR B., PETROVICH S., GINER-RIPOLL B. et al. Childhood central nervous system tumours - incidence and survival in Europe (1978-1997): Report from Automated Childhood Cancer Information System project. Eur. J. Cancer, 2006, 42: 2064-2080.
PIERRE-KAHN A., HIRSCH J. F., VINCHON M., PAYAN C., SAINTE-ROSE C.et al. Surgical management of brain-stem tumors in children: results and statistical analysis of 75 cases. J. Neurosurg., 1993, 79: 845-852.
POLLACK I. F. Brain tumors in children. N. Engl. J. Med., 1994, 331: 1500-1507.
RICKERT C. H., PROBST-COUSIN S., GULLOTTA F. Primary intracranial neoplasms of infancy and early childhood. Childs Nerv. Syst., 1997, 13: 507-513.
RUTKA J. T., KUO J. S., CARTER M., RAY A., UEDA S.et al. Advances in the treatment of pediatric brain tumors. Expert. Rev. Neurother., 2004, 4: 879-893.
SALCMAN M., SCHOLTZ H., KAPLAN R. S., KULIK S. Long-term survival in patients with malignant astrocytoma. Neurosurgery, 1994, 34: 213-219.
SPOSTO R., ERTEL I. J., JENKIN R. D., BOESEL C. P., VENES J. L.et al. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trial. A report from the Childrens Cancer Study Group. J. Neurooncol., 1989, 7: 165-177.
WISOFF J. H., BOYETT J. M., BERGER M. S., BRANT C., LI H. et al. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: A report of the Children's Cancer Group trial no. CCG-945. J. Neurosurg., 1998, 89: 52-59.